Korro Bio
KRRO
71 hedge funds and large institutions have $285M invested in Korro Bio in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 8 closing their positions.
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
57% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 14
11% more funds holding
Funds holding: 64 → 71 (+7)
0.79% more ownership
Funds ownership: 91% → 91.8% (+0.79%)
0% less capital invested
Capital invested by funds: $286M → $285M (-$416K)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4.31M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$3.34M |
| 3 |
BlackRock
New York
|
+$1.83M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.79M |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$14M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$5.81M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.51M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.32M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.22M |
KRRO Hedge Fund Activity: Q3 2024 in Review
71 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2024, worth a combined $285M — down 0.15% from $286M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new KRRO positions and 8 closed out — a net gain of 7 holders — while 22 added to existing stakes and 14 trimmed.
The largest buyer was Schonfeld Strategic Advisors, adding an estimated $4.31M. The largest seller was Artal Group, exiting entirely with an estimated $14M sold.
- 71 institutional investors held Korro Bio (KRRO) as of Q3 2024, up from 64 in Q2 2024.
- Funds reported $285M of Korro Bio stock for Q3 2024, down 0.15% quarter-over-quarter.
- 15 funds opened new Korro Bio positions in Q3 2024 and 8 closed out, a net change of +7 holders.
- The largest Korro Bio buyer in Q3 2024 was Schonfeld Strategic Advisors, an estimated $4.31M added.
- The largest Korro Bio seller in Q3 2024 was Artal Group, an estimated $14M sold.
Based on aggregated 13F filings for Q3 2024.